SCNI logo

SCNI
Scinai Immunotherapeutics Ltd.

5,704
Mkt Cap
$2.05M
Volume
8,001.00
52W High
$6.18
52W Low
$0.55
PE Ratio
-0.05
SCNI Fundamentals
Price
$0.5914
Prev Close
$0.592
Open
$0.58
50D MA
$0.7432
Beta
0.85
Avg. Volume
45,073.01
EPS (Annual)
-$3.59
P/B
0.12
Rev/Employee
$29,364.44
$7.75
Loading...
Loading...
News
all
press releases
Scinai Completes Strategic Reorganization to Establish Dedicated CDMO Platform and Lean R&D Structure; Outlines 2026 Priorities
Scinai Completes Strategic Reorganization to Establish Dedicated CDMO Platform and Lean R&D Structure; Outlines 2026 Priorities Scinai Completes Strategic Reorganization to Establish Dedicated CDMO...
PR Newswire·9d ago
News Placeholder
More News
News Placeholder
Scinai Reports Full-Year 2025 Results, with CDMO Revenues Doubling and Strategic Expansion Through Recipharm Collaboration
Scinai Reports Full-Year 2025 Results, with CDMO Revenues Doubling and Strategic Expansion Through Recipharm Collaboration Scinai Reports Full-Year 2025 Results, with CDMO Revenues Doubling and...
PR Newswire·13d ago
News Placeholder
Scinai Immunotherapeutics Highlights Expanded CDMO Platform and Immunology Pipeline at BIO-Europe Spring 2026
Scinai Immunotherapeutics Highlights Expanded CDMO Platform and Immunology Pipeline at BIO-Europe Spring 2026 Scinai Immunotherapeutics Highlights Expanded CDMO Platform and Immunology Pipeline at...
PR Newswire·26d ago
News Placeholder
Scinai Immunotherapeutics Receives Nasdaq Notification Regarding Minimum Bid Price
Scinai Immunotherapeutics Receives Nasdaq Notification Regarding Minimum Bid Price Scinai Immunotherapeutics Receives Nasdaq Notification Regarding Minimum Bid Price PR Newswire JERUSALEM, March 16...
PR Newswire·29d ago
News Placeholder
Scinai Signs Second Amendment to PinCell Option Agreement and Submits Revised 12 Million Non-Dilutive FENG Application to Advance PC111 Through Human Proof of Concept
Scinai Signs Second Amendment to PinCell Option Agreement and Submits Revised 12 Million Non-Dilutive FENG Application to Advance PC111 Through Human Proof of Concept Scinai Signs Second Amendment to...
PR Newswire·1mo ago
News Placeholder
Scinai Announces Expanded Israel Innovation Authority Support for Robotic Aseptic Fill & Finish Platform
Scinai Announces Expanded Israel Innovation Authority Support for Robotic Aseptic Fill & Finish Platform Scinai Announces Expanded Israel Innovation Authority Support for Robotic Aseptic Fill...
PR Newswire·2mo ago
News Placeholder
Scinai Announces Completion of Acquisition of Recipharm Israel Ltd. and Strategic Commercial Collaboration with Recipharm
Scinai Announces Completion of Acquisition of Recipharm Israel Ltd. and Strategic Commercial Collaboration with Recipharm Scinai Announces Completion of Acquisition of Recipharm Israel Ltd. and...
PR Newswire·2mo ago
News Placeholder
Scinai Reports Nine-Month 2025 Results as CDMO Growth Continues and NanoAbs Pipeline Advances
Scinai Reports Nine-Month 2025 Results as CDMO Growth Continues and NanoAbs Pipeline Advances Scinai Reports Nine-Month 2025 Results as CDMO Growth Continues and NanoAbs Pipeline Advances PR Newswire...
PR Newswire·4mo ago
<
...
1
>

Latest SCNI News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.